
GRDN Stock Forecast & Price Target
GRDN Analyst Ratings
Bulls say
Guardian Pharmacy Service is a strong investment opportunity due to their local leadership model which allows for flexibility in responding to market needs and better serving national account clients. Their financial flexibility and strong cash flow generation make them well-positioned for growth through acquisitions in the fragmented long-term care pharmacy industry. Additionally, their focus on customer service and use of technology are key drivers for cost savings, improved patient outcomes, and payer relationships. However, potential regulatory and reimbursement changes, as well as supply chain disruptions, are key risks to consider.
Bears say
Guardian Pharmacy Service is well positioned in the fragmented long-term care pharmacy industry, with a strong suite of technology assets and an attractive offering for patients, facilities, and payors. However, their negative cash flow and high level of expenditures raise concerns about their overall financial health, and any potential regulatory or reimbursement changes could negatively impact their business and share performance. As a result, we have a negative outlook on this stock.
This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.
GRDN Analyst Forecast & Price Prediction
Start investing in GRDN
Order type
Buy in
Order amount
Est. shares
0 shares